2018-2023 Global Hematological Malignancies Market Report (Status and Outlook)

October 2018 | 116 pages | ID: 294EF03DBE7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Hematological Malignancies market for 2018-2023.
Hematologic malignancies are forms of cancer that begin in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system.

Over the next five years, LPI(LP Information) projects that Hematological Malignancies will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Hematological Malignancies market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Leukemia
• Lymphoma

Segmentation by application:

• Hospital Pharmacies
• Medical Stores
• E-commerce Platform

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• AbbVie
• Bristol-Myers Squibb
• Celgene
• Roche
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
• Pfizer
• Teva Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Hematological Malignancies market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Hematological Malignancies market by identifying its various subsegments.
• Focuses on the key global Hematological Malignancies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Hematological Malignancies with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Hematological Malignancies submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL HEMATOLOGICAL MALIGNANCIES MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hematological Malignancies Market Size 2013-2023
  2.1.2 Hematological Malignancies Market Size CAGR by Region
2.2 Hematological Malignancies Segment by Type
  2.2.1 Leukemia
  2.2.2 Lymphoma
  2.2.3 Myeloma
2.3 Hematological Malignancies Market Size by Type
  2.3.1 Global Hematological Malignancies Market Size Market Share by Type (2013-2018)
  2.3.2 Global Hematological Malignancies Market Size Growth Rate by Type (2013-2018)
2.4 Hematological Malignancies Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Medical Stores
  2.4.3 E-commerce Platform
2.5 Hematological Malignancies Market Size by Application
  2.5.1 Global Hematological Malignancies Market Size Market Share by Application (2013-2018)
  2.5.2 Global Hematological Malignancies Market Size Growth Rate by Application (2013-2018)

3 GLOBAL HEMATOLOGICAL MALIGNANCIES BY PLAYERS

3.1 Global Hematological Malignancies Market Size Market Share by Players
  3.1.1 Global Hematological Malignancies Market Size by Players (2016-2018)
  3.1.2 Global Hematological Malignancies Market Size Market Share by Players (2016-2018)
3.2 Global Hematological Malignancies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HEMATOLOGICAL MALIGNANCIES BY REGIONS

4.1 Hematological Malignancies Market Size by Regions
4.2 Americas Hematological Malignancies Market Size Growth
4.3 APAC Hematological Malignancies Market Size Growth
4.4 Europe Hematological Malignancies Market Size Growth
4.5 Middle East & Africa Hematological Malignancies Market Size Growth

5 AMERICAS

5.1 Americas Hematological Malignancies Market Size by Countries
5.2 Americas Hematological Malignancies Market Size by Type
5.3 Americas Hematological Malignancies Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Hematological Malignancies Market Size by Countries
6.2 APAC Hematological Malignancies Market Size by Type
6.3 APAC Hematological Malignancies Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Hematological Malignancies by Countries
7.2 Europe Hematological Malignancies Market Size by Type
7.3 Europe Hematological Malignancies Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hematological Malignancies by Countries
8.2 Middle East & Africa Hematological Malignancies Market Size by Type
8.3 Middle East & Africa Hematological Malignancies Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL HEMATOLOGICAL MALIGNANCIES MARKET FORECAST

10.1 Global Hematological Malignancies Market Size Forecast (2018-2023)
10.2 Global Hematological Malignancies Forecast by Regions
  10.2.1 Global Hematological Malignancies Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Hematological Malignancies Forecast by Type
10.8 Global Hematological Malignancies Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 Company Details
  11.1.2 Hematological Malignancies Product Offered
  11.1.3 AbbVie Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 AbbVie News
11.2 Bristol-Myers Squibb
  11.2.1 Company Details
  11.2.2 Hematological Malignancies Product Offered
  11.2.3 Bristol-Myers Squibb Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Bristol-Myers Squibb News
11.3 Celgene
  11.3.1 Company Details
  11.3.2 Hematological Malignancies Product Offered
  11.3.3 Celgene Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Celgene News
11.4 Roche
  11.4.1 Company Details
  11.4.2 Hematological Malignancies Product Offered
  11.4.3 Roche Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Roche News
11.5 GlaxoSmithKline
  11.5.1 Company Details
  11.5.2 Hematological Malignancies Product Offered
  11.5.3 GlaxoSmithKline Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 GlaxoSmithKline News
11.6 Johnson & Johnson
  11.6.1 Company Details
  11.6.2 Hematological Malignancies Product Offered
  11.6.3 Johnson & Johnson Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Johnson & Johnson News
11.7 Novartis
  11.7.1 Company Details
  11.7.2 Hematological Malignancies Product Offered
  11.7.3 Novartis Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Novartis News
11.8 Pfizer
  11.8.1 Company Details
  11.8.2 Hematological Malignancies Product Offered
  11.8.3 Pfizer Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Pfizer News
11.9 Teva Pharmaceutical
  11.9.1 Company Details
  11.9.2 Hematological Malignancies Product Offered
  11.9.3 Teva Pharmaceutical Hematological Malignancies Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Teva Pharmaceutical News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Hematological Malignancies
Figure Hematological Malignancies Report Years Considered
Figure Market Research Methodology
Figure Global Hematological Malignancies Market Size Growth Rate 2013-2023 ($ Millions)
Table Hematological Malignancies Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Leukemia
Table Major Players of Lymphoma
Table Major Players of Myeloma
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Hematological Malignancies Market Size Market Share by Type (2013-2018)
Figure Global Hematological Malignancies Market Size Market Share by Type (2013-2018)
Figure Global Leukemia Market Size Growth Rate
Figure Global Lymphoma Market Size Growth Rate
Figure Global Myeloma Market Size Growth Rate
Figure Hematological Malignancies Consumed in Hospital Pharmacies
Figure Global Hematological Malignancies Market: Hospital Pharmacies (2013-2018) ($ Millions)
Figure Global Hospital Pharmacies YoY Growth ($ Millions)
Figure Hematological Malignancies Consumed in Medical Stores
Figure Global Hematological Malignancies Market: Medical Stores (2013-2018) ($ Millions)
Figure Global Medical Stores YoY Growth ($ Millions)
Figure Hematological Malignancies Consumed in E-commerce Platform
Figure Global Hematological Malignancies Market: E-commerce Platform (2013-2018) ($ Millions)
Figure Global E-commerce Platform YoY Growth ($ Millions)
Table Global Hematological Malignancies Market Size by Application (2013-2018) ($ Millions)
Table Global Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure Global Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure Global Hematological Malignancies Market Size in Hospital Pharmacies Growth Rate
Figure Global Hematological Malignancies Market Size in Medical Stores Growth Rate
Figure Global Hematological Malignancies Market Size in E-commerce Platform Growth Rate
Table Global Hematological Malignancies Revenue by Players (2016-2018) ($ Millions)
Table Global Hematological Malignancies Revenue Market Share by Players (2016-2018)
Figure Global Hematological Malignancies Revenue Market Share by Players in 2017
Table Global Hematological Malignancies Key Players Head office and Products Offered
Table Hematological Malignancies Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Hematological Malignancies Market Size by Regions 2013-2018 ($ Millions)
Table Global Hematological Malignancies Market Size Market Share by Regions 2013-2018
Figure Global Hematological Malignancies Market Size Market Share by Regions 2013-2018
Figure Americas Hematological Malignancies Market Size 2013-2018 ($ Millions)
Figure APAC Hematological Malignancies Market Size 2013-2018 ($ Millions)
Figure Europe Hematological Malignancies Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Hematological Malignancies Market Size 2013-2018 ($ Millions)
Table Americas Hematological Malignancies Market Size by Countries (2013-2018) ($ Millions)
Table Americas Hematological Malignancies Market Size Market Share by Countries (2013-2018)
Figure Americas Hematological Malignancies Market Size Market Share by Countries in 2017
Table Americas Hematological Malignancies Market Size by Type (2013-2018) ($ Millions)
Table Americas Hematological Malignancies Market Size Market Share by Type (2013-2018)
Figure Americas Hematological Malignancies Market Size Market Share by Type in 2017
Table Americas Hematological Malignancies Market Size by Application (2013-2018) ($ Millions)
Table Americas Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure Americas Hematological Malignancies Market Size Market Share by Application in 2017
Figure United States Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Canada Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Table APAC Hematological Malignancies Market Size by Countries (2013-2018) ($ Millions)
Table APAC Hematological Malignancies Market Size Market Share by Countries (2013-2018)
Figure APAC Hematological Malignancies Market Size Market Share by Countries in 2017
Table APAC Hematological Malignancies Market Size by Type (2013-2018) ($ Millions)
Table APAC Hematological Malignancies Market Size Market Share by Type (2013-2018)
Figure APAC Hematological Malignancies Market Size Market Share by Type in 2017
Table APAC Hematological Malignancies Market Size by Application (2013-2018) ($ Millions)
Table APAC Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure APAC Hematological Malignancies Market Size Market Share by Application in 2017
Figure China Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Japan Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Korea Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure India Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Australia Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Table Europe Hematological Malignancies Market Size by Countries (2013-2018) ($ Millions)
Table Europe Hematological Malignancies Market Size Market Share by Countries (2013-2018)
Figure Europe Hematological Malignancies Market Size Market Share by Countries in 2017
Table Europe Hematological Malignancies Market Size by Type (2013-2018) ($ Millions)
Table Europe Hematological Malignancies Market Size Market Share by Type (2013-2018)
Figure Europe Hematological Malignancies Market Size Market Share by Type in 2017
Table Europe Hematological Malignancies Market Size by Application (2013-2018) ($ Millions)
Table Europe Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure Europe Hematological Malignancies Market Size Market Share by Application in 2017
Figure Germany Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure France Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure UK Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Italy Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Russia Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Spain Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Hematological Malignancies Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Hematological Malignancies Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Hematological Malignancies Market Size Market Share by Countries in 2017
Table Middle East & Africa Hematological Malignancies Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Hematological Malignancies Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Hematological Malignancies Market Size Market Share by Type in 2017
Table Middle East & Africa Hematological Malignancies Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Hematological Malignancies Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Hematological Malignancies Market Size Market Share by Application in 2017
Figure Egypt Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Israel Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Hematological Malignancies Market Size Growth 2013-2018 ($ Millions)
Figure Global Hematological Malignancies arket Size Forecast (2018-2023) ($ Millions)
Table Global Hematological Malignancies Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Hematological Malignancies Market Size Market Share Forecast by Regions
Figure Americas Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure APAC Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Europe Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure United States Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Canada Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Mexico Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Brazil Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure China Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Japan Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Korea Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure India Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Australia Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Germany Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure France Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure UK Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Italy Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Russia Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Spain Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Egypt Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure South Africa Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Israel Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure Turkey Hematological Malignancies Market Size 2018-2023 ($ Millions)
Figure GCC Countries Hematological Malignancies Market Size 2018-2023 ($ Millions)
Table Global Hematological Malignancies Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Hematological Malignancies Market Size Market Share Forecast by Type (2018-2023)
Table Global Hematological Malignancies Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Hematological Malignancies Market Size Market Share Forecast by Application (2018-2023)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure AbbVie Hematological Malignancies Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Hematological Malignancies Market Share (2016-2018)
Table Celgene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celgene Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Celgene Hematological Malignancies Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Roche Hematological Malignancies Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Head Office, Major Market Areas and Its Competitors
Table GlaxoSmithKline Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure GlaxoSmithKline Hematological Malignancies Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table Johnson & Johnson Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Johnson & Johnson Hematological Malignancies Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Novartis Hematological Malignancies Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Pfizer Hematological Malignancies Market Share (2016-2018)
Table Teva Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Hematological Malignancies Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Hematological Malignancies Market Share (2016-2018)